자가면역·알레르기·염증질환 대상 항체신약(이중항체 포함) 개발 기업 모음.
For reference only. Not investment advice. You are solely responsible for your investment decisions.
자가면역·알레르기·염증질환 대상 항체신약(이중항체 포함) 개발 기업 모음.. This sector includes 7 stocks. Click any stock below to view detailed analysis, real-time price, and performance data.
7/6 · Real-time
No gainers
Of 7 자가면역 항체신약 관련주 stocks tracked today, 0 are up and 7 down (avg -4.00%), an overall weak tone. The top gainer is 유한양행 (-1.14%), while 에이프릴바이오 (-6.42%) lags the group.
Based on live prices and updated periodically. Not investment advice.
Analyze 자가면역 항체신약 관련주 deeper
Reviewed all 7 자가면역 항체신약 관련주 stocks? Dig deeper with these tools.